Skip to main content
OpenTrials

Clinical trial condition

Triple-negative Breast Cancer

Explore clinical trials studying Triple-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

80 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Triple-negative Breast Cancer trial results

Completed

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

NCT02307240

Conditions
Breast Diseases, Breast Neoplasms, High-grade Serous Ovarian Cancer, +8 more
Locations
  • UCSF School of Medicine San Francisco, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

NCT01881230

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Arizona Cancer Research Alliance Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
View all 140 locations
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

NCT00733408

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Yuma Cancer Center Yuma, Arizona, United States
View all 17 locations
View Trial Details
Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

NCT01986426

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • Jules Bordet Institute Brussels, Belgium
  • Cliniques Universitaires St-Luc, Service d'oncologie médicale Brussels, Belgium
  • Institut Curie Paris, France
  • Institute Gustave Roussy Paris, France
View all 14 locations
View Trial Details
Completed

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT01091454

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +6 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 266 locations
View Trial Details
Completed

Phase II ABT-888 With Cyclophosphamide

NCT01306032

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +24 more
Locations
  • University of California, Davis Davis, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details

Related conditions